Good ol' trypsin--any reason why not?

JPK

On Mon, Sep 5, 2011 at 5:40 PM, Huang, Jing <jinghu...@mednet.ucla.edu> wrote:
> Excellent point indeed. We always include (at least one, preferably multiple) 
> control proteins that are proteolysed equally across to make sure that the 
> observed "target stabilization" is not due to fortuitous protease inhibition.
>
> What protease did you use for your nucleotide binding case? The protease 
> sometimes matters. For example, thermolysin mainly only digests proteins that 
> are unfolded, whereas pronase, which is a mixture of various proteases, can 
> digest both folded and unfolded proteins.
>
> Best,
> Jing
>
> --
> Jing Huang, Ph.D.
> Associate Professor
> UCLA
> Department of Molecular & Medical Pharmacology
> 310-825-4329
> jinghuang at mednet dot ucla dot edu
> http://labs.pharmacology.ucla.edu/huanglab/
>
> ________________________________________
> From: Jacob Keller [j-kell...@fsm.northwestern.edu]
> Sent: Monday, September 05, 2011 12:18 PM
> To: Huang, Jing
> Cc: CCP4BB@JISCMAIL.AC.UK
> Subject: Re: [ccp4bb] Trying to "digest" PISA results
>
> I did a similar assay years ago, but since the results were negative,
> never published anything--it was seeing whether nucleotides bound to
> my protein of interest by time courses of proteolysis +/- nucleotide.
> One tricky part of the assay, however, is to be sure that the compound
> of interest doesn't inhibit the protease--did you address that? I
> guess you would have to have some control proteins for that...
>
> Jacob
>
>
> g
>>
>> --
>> Jing Huang, Ph.D.
>> Associate Professor
>> UCLA
>> Department of Molecular & Medical Pharmacology
>> 310-825-4329
>> jinghuang at mednet dot ucla dot edu
>> http://labs.pharmacology.ucla.edu/huanglab/
>>
>> ________________________________________
>> From: CCP4 bulletin board [CCP4BB@JISCMAIL.AC.UK] On Behalf Of Jacob Keller 
>> [j-kell...@fsm.northwestern.edu]
>> Sent: Monday, September 05, 2011 10:10 AM
>> To: CCP4BB@JISCMAIL.AC.UK
>> Subject: Re: [ccp4bb] Trying to "digest" PISA results
>>
>> NMR...take that!
>>
>> JPK
>>
>> 2011/9/5 Andreas Förster <docandr...@gmail.com>:
>>> AUC !
>>>
>>>
>>> Andreas
>>>
>>>
>>>
>>> On 05/09/2011 6:00, Jacob Keller wrote:
>>>>
>>>> mea culpa! How about FRET?
>>>>
>>>> JPK
>>>>
>>>> On Mon, Sep 5, 2011 at 11:39 AM, Bosch, Juergen<jubo...@jhsph.edu>  wrote:
>>>>>
>>>>> Hi Jacob,
>>>>> you forgot cross-linking to stabilize a weak complex and verify that it
>>>>> exists.
>>>>> Jürgen
>>>>> On Sep 5, 2011, at 11:45 AM, Jacob Keller wrote:
>>>>>
>>>>> Well, I guess I have always been curious what is the gold standard
>>>>> here--perhaps SEC, ITC, SPR, pulldowns? What if SEC shows a
>>>>> polydisperse sample with weak oligomerization, or SPR a very weak
>>>>> binding constant? Do we then revert to a functional assay? Or what if
>>>>> the functional assay does not show anything, but the binding constant
>>>>> is really strong? Or vice versa, the binding is completely
>>>>> undetectable, but the functional assay shows something?
>>>>>
>>>>> JPK
>>>>>
>>>
>>>
>>> --
>>>        Andreas Förster, Research Associate
>>>        Paul Freemont & Xiaodong Zhang Labs
>>> Department of Biochemistry, Imperial College London
>>>            http://www.msf.bio.ic.ac.uk
>>>
>>
>>
>>
>> --
>> *******************************************
>> Jacob Pearson Keller
>> Northwestern University
>> Medical Scientist Training Program
>> cel: 773.608.9185
>> email: j-kell...@northwestern.edu
>> *******************************************
>>
>> IMPORTANT WARNING:  This email (and any attachments) is only intended for 
>> the use of the person or entity to which it is addressed, and may contain 
>> information that is privileged and confidential.  You, the recipient, are 
>> obligated to maintain it in a safe, secure and confidential manner.  
>> Unauthorized redisclosure or failure to maintain confidentiality may subject 
>> you to federal and state penalties. If you are not the intended recipient, 
>> please immediately notify us by return email, and delete this message from 
>> your computer.
>>
>
>
>
> --
> *******************************************
> Jacob Pearson Keller
> Northwestern University
> Medical Scientist Training Program
> cel: 773.608.9185
> email: j-kell...@northwestern.edu
> *******************************************
>
> IMPORTANT WARNING:  This email (and any attachments) is only intended for the 
> use of the person or entity to which it is addressed, and may contain 
> information that is privileged and confidential.  You, the recipient, are 
> obligated to maintain it in a safe, secure and confidential manner.  
> Unauthorized redisclosure or failure to maintain confidentiality may subject 
> you to federal and state penalties. If you are not the intended recipient, 
> please immediately notify us by return email, and delete this message from 
> your computer.
>



-- 
*******************************************
Jacob Pearson Keller
Northwestern University
Medical Scientist Training Program
cel: 773.608.9185
email: j-kell...@northwestern.edu
*******************************************

Reply via email to